This Week in The Roadhouse Pharmacy

THE ROADHOUSE PHARMACY: There’s a great deal of interest in the Bio-tech sector at the moment, so we have opened our own Pharmacy to keep our readers up to speed.

SomnoMed hits 28 per cent volume growth in Q3

SomnoMed Limited (ASX: SOM) announced it has increased sales volume by 28.3 per cent in Q3, compared to the same quarter in the previous year. READ MORE…

New version ReCell launched in UK and Europe

Regenerative medicine company Avita Medical (ASX: AVH) has developed and released to market a new version of ReCell® ‘Spray‐on Skin®’ that no longer requires refrigeration. READ MORE…

Starpharma expands drug delivery program with AstraZeneca

Starpharma Holdings (ASX: SPL) has signed a second, expanded agreement with AstraZeneca in the field of cancer medicine using Starpharma’s proprietary DEP™ dendrimer drug delivery technology. READ MORE…

US Patent allowance extends strong IP position

Antisense Therapeutics (ASX: ANP) has been informed the US Patent Office has allowed US Patent 61/132973 entitled ‘Methods for treating multiple sclerosis (MS) using antisense oligonucleotides’. READ MORE…